The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding
Open accessAbstract
BACKGROUND: Bacterial infections are a frequent complication in patients with cirrhosis and upper gastrointestinal bleeding. Antibiotic prophylaxis seems to decrease the incidence of bacterial infections. Oral antibiotics, active against enteric bacteria, have been commonly used as antibiotic prophylaxis in patients with cirrhosis and upper gastrointestinal bleeding. This is an update of a Cochrane review first published in 2002. OBJECTIVES: To assess the benefits and harms of antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding. SEARCH STRATEGY: We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Index EXPANDED until June 2010. In addition, we handsearched the references of all identified studies. SELECTION CRITERIA: Randomised clinical trials comparing different types of antibiotic prophylaxis with no intervention, placebo, or another antibiotic to prevent bacterial infections in cirrhotic patients with upper gastrointestinal bleeding. DATA COLLECTION AND ANALYSIS: Three authors independently assessed trial quality, risk of bias, and extracted data. We contacted study authors for additional information. Association measures were relative risk (RR) for dichotomous outcomes and mean difference (MD) for continuous outcomes. MAIN RESULTS: Twelve trials (1241 patients) evaluated antibiotic prophylaxis compared with placebo or no antibiotic prophylaxis. All trials were at risk of bias. Antibiotic prophylaxis compared with no intervention or placebo was associated with beneficial effects on mortality (RR 0.79, 95% CI 0.63 to 0.98), mortality from bacterial infections (RR 0.43, 95% CI 0.19 to 0.97), bacterial infections (RR 0.36, 95% CI 0.27 to 0.49), rebleeding (RR 0.53, 95% CI 0.38 to 0.74), days of hospitalisation (MD -1.91, 95% CI -3.80 to -0.02), bacteraemia (RR 0.25, 95% CI 0.15 to 0.40), pneumonia (RR 0.45, 95% CI 0.27 to 0.75), spontaneous bacterial peritonitis (RR 0.29, 95% CI 0.15 to 0.57), and urinary tract infections (RR 0.23, 95% CI 0.12 to 0.41). No serious adverse events were reported. The trials showed no significant heterogeneity of effects. Another five trials (650 patients) compared different antibiotic regimens. Data could not be combined as each trial used different antibiotic regimen. None of the examined antibiotic regimen was superior to the control regimen regarding mortality or bacterial infections. AUTHORS' CONCLUSIONS: Prophylactic antibiotic use in patients with cirrhosis and upper gastrointestinal bleeding significantly reduced bacterial infections, and seems to have reduced all-cause mortality, bacterial infection mortality, rebleeding events, and hospitalisation length. These benefits were observed independently of the type of antibiotic used; thus, no specific antibiotic can be preferred. Therefore, antibiotic selection should be made considering local conditions such as bacterial resistance profile and treatment cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Abraham, J. (2010) · Handbook of Transnational Economic Governance Regimes · doi:10.1163/ej.9789004163300.i-1081.897 · Cited by 2,582
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.013 · Cited by 1,881
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., & Carey, W. (2007) · Hepatology · doi:10.1002/hep.21907 · Cited by 1,722
Varices, T. N. I. E. C. F. T. S. A. T. O. E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191505 · Cited by 1,173
Brok, J., Thorlund, K., Gluud, C., & Wetterslev, J. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.10.007 · Cited by 1,113
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Rimola, A., García-Tsao, G., Navasa, M., Piddock, L. J. V., Planas, R., Bernard, B., & Inadomi, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80201-9 · Cited by 1,064
Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Brocchi, E., Caletti, G., Brambilla, G., Mantia, L. L., Lupinacci, G., Pisano, G., Puerari, G., Zambelli, A., Barbagli, S., Ciani, P. A., et al. (1988) · New England Journal of Medicine · Cited by 872
Bernard, B., Grangé, J.-D., Khac, E. N., Amiot, X., Opolon, P., & Poynard, T. (1999) · Hepatology · doi:10.1002/hep.510290608 · Cited by 836
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Thorlund, K., Devereaux, P. J., Wetterslev, J., Guyatt, G., Ioannidis, J. P. A., Thabane, L., Gluud, L.-L., Als-Nielsen, B., & Gluud, C. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn179 · Cited by 833
Kunz, R., & Oxman, A. D. (1998) · BMJ · doi:10.1136/bmj.317.7167.1185 · Cited by 770
The clinical use of HVPG measurements in chronic liver disease
Bosch, J., Abraldes, J. G., Berzigotti, A., & García-Pagan, J. C. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.149 · Cited by 727
Royle, P., & Milne, R. (2003) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462303000552 · Cited by 693
Ginés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Section XXIV. Partition Chromatographs
(2009) · Biotechnology · doi:10.1201/9781420084498-31 · Cited by 590
Fernández, J., del Arbol, L. R., Gómez, C., Durandez, R., Serradilla, R., Guarner, C., Planas, R., Arroyo, V., & Navasa, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.010 · Cited by 458
Goulis, J., Armonis, A., Patch, D., Sabin, C., Greenslade, L., & Burroughs, A. K. (1998) · Hepatology · doi:10.1002/hep.510270504 · Cited by 435
Hou, M.-C., Lin, H.-C., Liu, T.-T., Kuo, B. I.-T., Lee, F.-Y., Chang, F.-Y., & Lee, S.-D. (2004) · Hepatology · doi:10.1002/hep.20126 · Cited by 429
Spontaneous Bacterial Peritonitis
Such, J., & Runyon, B. A. (1998) · Clinical Infectious Diseases · doi:10.1086/514940 · Cited by 404
The management of portal hypertension: Rational basis, available treatments and future options
Bosch, J., Berzigotti, A., Garcia-Pagan, J. C., & Abraldes, J. G. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.021 · Cited by 319
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
Soriano, G., Guarner, C., Tomás, A., Villanueva, C., Torras, X., González, D., Sainz, S., Anguera, A., Cussó, X., Balanzó, J., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91514-5 · Cited by 315
Bacterial infection in the pathogenesis of variceal bleeding
Goulis, J., Patch, D., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06020-6 · Cited by 286
and Members of the Veterans Affairs Hepatitis C Resource Center Program, Garcia-Tsao, G., & Lim, J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.191 · Cited by 251
Oral, Nonabsorbable Antibiotics Prevent Infection in Cirrhotics With Gastrointestinal Hemorrhage
Rimola, A., Bory, F., Teres, J., Perez-Ayuso, R. M., Arroyo, V., & Rodes, J. (1985) · Hepatology · doi:10.1002/hep.1840050320 · Cited by 249
Assessing the Quality of Randomised Controlled Trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch5 · Cited by 238
Singh, N., Gayowski, T., Yu, V. L., & Wagener, M. M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00007 · Cited by 203
Pauwels, A., Mostefa-Kara, N., Debenes, B., Degoutte, E., & Levy, V (1996) · Hepatology · doi:10.1002/hep.510240408 · Cited by 197
Novella, M., Sola, R., Soriano, G., Andreu, M., Gana, J., Ortiz, J., Coll, S., Sabat, M., Vila, M. C., Guarner, C., et al. (1997) · Hepatology · doi:10.1002/hep.510250306 · Cited by 196
Blaise, M., Pateron, D., Trinchet, J.-C., Levacher, S., Beaugrand, M., & Pourriat, J.-L. (1994) · Hepatology · doi:10.1002/hep.1840200107 · Cited by 192
Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding
Soares‐Weiser, K., Brezis, M., Tur-Kaspa, R., & Leibovici, L. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002907 · Cited by 175
Self-citationRisk factors for the development of bacterial infections in hospitalized patients with cirrhosis
Deschênes, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00349-4 · Cited by 170
Augustin, S., Muntaner, L., Altamirano, J. T., González, A., Saperas, E., Dot, J., Abu–Suboh, M., Armengol, J. R., Malagelada, J. R., Esteban, R., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.08.011 · Cited by 169
Impact of antibiotic resistance on clinical outcomes and the cost of care
Niederman, M. S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104001-00011 · Cited by 167
Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage
Bleichner, G., Boulanger, R., Squara, P., Sollet, J.-P., & Parent, A. (1986) · British journal of surgery · doi:10.1002/bjs.1800730916 · Cited by 156
Bacterial Infections in Liver Disease
Navasa, M., Rimola, A., & Rodés, J. (1997) · Seminars in Liver Disease · doi:10.1055/s-2007-1007209 · Cited by 152
Hsieh, W.-J., Lin, H., Hwang, S.-J., Hou, M., Lee, F., Chang, F., & Lee, S. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00169-5 · Cited by 145
Infections Caused By Escherichia Coli Resistant to Norfloxacin in Hospitalized Cirrhotic Patients
Ortiz, J., Vila, M. C., Soriano, G., Miñana, J. M., Gana, J., Mirelis, B., Novella, M. T., Coll, S., Sàbat, M., Andreu, M. G., et al. (1999) · Hepatology · doi:10.1002/hep.510290406 · Cited by 141
Genetic predisposition to drug-induced hepatotoxicity
Larrey, D. G., & Pageaux, G. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80492-8 · Cited by 101
Jun, C., Park, C., Lee, W., Joo, Y., Kim, H., Choi, S.-K., Rew, J., Kim, S.-J., & Kim, Y.-D. (2006) · Journal of Korean Medical Science · doi:10.3346/jkms.2006.21.5.883 · Cited by 71
Spontaneous bacterial peritonitis: An update on evaluation, management, and prevention
Bhuva, M., Ganger, D. R., & Jensen, D. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90027-2 · Cited by 61
Spontaneous bacterial peritonitis in liver cirrhosis: Treatment and prophylaxis
Arroyo, V., Navasa, M., & Rimola, A. (1994) · Infection · doi:10.1007/bf01782702 · Cited by 36
Zhao, C., Chen, S., Zhou, J.-P., Xiao, W., Fan, H.-G., Wu, X.-W., Feng, G.-X., & He, W.-X. (2002) · PubMed · Cited by 20
Antimicrobial Therapy in Patients with Acute Variceal Hemorrhage
Wilbur, K., & Sidhu, K. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/759360 · Cited by 8
Cited by
(2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.004 · Cited by 1,725
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., & Carey, W. (2007) · Hepatology · doi:10.1002/hep.21907 · Cited by 1,722
Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.024 · Cited by 906
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Upper Digestive Bleeding in Cirrhosis. Post–Therapeutic Outcome and Prognostic Indicators
D'Amico, G., & De Franchis, R. (2003) · Hepatology · doi:10.1053/jhep.2003.50385 · Cited by 907
Metadata
- Authors
- Chavez-Tapia, N. C., Barrientos-Gutierrez, T., Tellez-Avila, F. I., Soares-Weiser, K., & Uribe, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-09-08
- Volume
- 2010
- Issue
- 9
- Pages
- CD002907-CD002907
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1845618022
- Cited by
- 304
- References
- 51
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.